Wade Thompson (@wadddee) 's Twitter Profile
Wade Thompson

@wadddee

Pharmacist/researcher ensuring older persons are taking medications that are a good fit, often through #deprescribing | Asst Prof @UBCmedicine @Drug_Evidence

ID: 847927926326792193

calendar_today31-03-2017 21:45:46

863 Tweet

954 Takipçi

758 Takip Edilen

European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Differences in LDL-C reporting by laboratories using different methods have significant impact on therapeutic decisions: a new registry-based study published #openaccess in #EHJPharmacotherapy bit.ly/3VtiV8n EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli Anton Pottegård

Differences in LDL-C reporting by laboratories using different methods have significant impact on therapeutic decisions: a new registry-based study published #openaccess in #EHJPharmacotherapy bit.ly/3VtiV8n

<a href="/EditorEHJCVP/">EHJ-CVP Editor-in-Chief</a> <a href="/FeliceGragnano/">Felice Gragnano</a> <a href="/MattiaGalli10/">Mattia Galli</a> <a href="/Pottegard/">Anton Pottegård</a>
JAGS (@agsjournal) 's Twitter Profile Photo

Risk factors for urinary tract infections among nursing home residents initiating sodium-glucose cotransporter-2 inhibitors. #geriatrics agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…

Therapeutics Initiative (@drug_evidence) 's Twitter Profile Photo

🎺Registration now OPEN for our #BestEvidence for Clinicians annual course! bit.ly/3xmmuVP🎺 ✅highly interactive👥 ☑️engaging expert speakers 🧑🏽‍💻 ✅common + new 💊 tx issues ☑️independent + evidence-based 💯 ✅broad, practical scope 🩺 #CME #MedEd #DrugEvidence24

🎺Registration now OPEN for our #BestEvidence for Clinicians annual course!  bit.ly/3xmmuVP🎺

✅highly interactive👥
☑️engaging expert speakers 🧑🏽‍💻 
✅common + new 💊 tx issues 
☑️independent + evidence-based 💯 
✅broad, practical scope 🩺

#CME #MedEd #DrugEvidence24
Anton Pottegård (@pottegard) 's Twitter Profile Photo

📣Free course: Introduction to pharmacoepidemiology!🤓 I've prepared a 10-step, 3-hour introductory course. Find it on Youtube or my website. This course is intended for newcomers to pharmacoepidemiology, and I really hope people will find it useful🥳 #academia #epidemiology

📣Free course: Introduction to pharmacoepidemiology!🤓

I've prepared a 10-step, 3-hour introductory course. Find it on Youtube or my website.

This course is intended for newcomers to pharmacoepidemiology, and I really hope people will find it useful🥳

#academia #epidemiology
NEJM (@nejm) 's Twitter Profile Photo

Presented at #ESCardio: Among patients with a previous myocardial infarction, interruption of long-term beta-blocker therapy was not found to be noninferior to continuation with respect to adverse events at a median of 3 years. Full ABYSS trial results: nej.md/3MeRHOi

Presented at #ESCardio: 

Among patients with a previous myocardial infarction, interruption of long-term beta-blocker therapy was not found to be noninferior to continuation with respect to adverse events at a median of 3 years. Full ABYSS trial results: nej.md/3MeRHOi
Taiaiake (@taiaiakealfred) 's Twitter Profile Photo

In honour of the upcoming National Day for Truth and Reconciliation, I'll be speaking at an event in Orangeville, Ontario on September 26th. The County of Dufferin is hosting me to deliver a keynote speech on the subject of Truth and Reconciliation, with a particular focus on